Quest diagnostics to discuss strategic priorities to drive growth and create shareholder value at 2023 investor day

Updates 2023-26 compound annual growth rate (cagr): revenues expected to grow at mid single-digit rate; adjusted diluted earnings per share (eps)* expected to grow at high single-digit rate recommits to invigorate savings and productivity improvements of approximately 3% annually guidance for 2023 provided on february 2, 2023 remains unchanged secaucus, n.j. , march 16, 2023 /prnewswire/ -- at a meeting with analysts and investors at its investor day, members of the executive leadership team of quest diagnostics incorporated (nyse: dgx), the world's leading provider of diagnostic information services, will discuss the company's priorities to grow revenues and create shareholder value.
DGX Ratings Summary
DGX Quant Ranking